openPR Logo
Press release

Clinical Trial Management System Market by Oracle (US), Medidata Solutions (US), PAREXEL (US), Bioclinica (US), Bio-Optronics (US), and IBM (US) and Dominated Due to Pharma & Biopharmaceutical Co., Medical Device Co., CROs End Users to 2022

04-12-2019 02:58 PM CET | Health & Medicine

Press release from: ReportsnReports

Clinical Trial Management System Market

Clinical Trial Management System Market

Download Free PDF Sample of Clinical Trial Management System Market Study Now Available at https://www.reportsnreports.com/contacts/requestsample.aspx?name=126572 .

Clinical trial management system market is projected to reach USD 1,065.6 million by 2022 from USD 590 Million in 2017, at a CAGR of 12.6%. Report studies the clinical trial management market based on type, delivery mode, component, end user, and region. The report also studies factors (such as drivers, restraints, opportunities, and challenges) affecting market growth.

Analysis-industry trends, clinical trial management system market ranking of top players, & company profiles, which together form basic views & analyze competitive landscape, emerging segments of CTMS market, & high-growth regions & drivers, restraints, challenges, & opportunities. Report will help both established firms & new entrants/smaller firms to gauge pulse of market & greater market shares.

Global Clinical trial management system market is segmented into web-based (on-demand), licensed enterprise (on premise), and cloud-based (SaaS) segments. The cloud-based (SaaS) segment is estimated to witness the highest growth during the forecast period, primarily due to the rising adoption of cloud-based solutions in medical research studies owing to various benefits offered by them such as low cost, high security, privacy, and easy accessibility from any device.

Click Here for More Information on Clinical Trial Management System Market Now at https://www.reportsnreports.com/purchase.aspx?name=126572 .

Major factors driving growth of clinical trial management system market include the increasing partnerships between biopharma companies and CROs, rising number of ongoing clinical trials, rising government funding & grants to support clinical trials, availability of advanced CTMS solutions, and growing customer base for CTMS solutions.

Global clinical trial management system market is segmented into web-based (on-demand), licensed enterprise (on premise), and cloud-based (SaaS) segments. Cloud-based (SaaS) segment is estimated to witness highest growth during forecast period, primarily due to rising adoption of cloud-based solutions in medical research studies owing to various benefits offered by them like low cost, high security, privacy, & easy accessibility from any device.

Top players in clinical trial management market are Oracle (US), Medidata Solutions (US), PAREXEL (US), Bioclinica (US), Bio-Optronics (US), & IBM (US). Clinical trial management system market research study involves extensive use of secondary sources, directories, & databases (like Dun & Bradstreet, Bloomberg Business, & Factiva), to identify and collect information useful for this technical, market-oriented, & financial study of market.

Key Target Audience:
• Healthcare IT service providers
• Pharmaceutical/biopharmaceutical companies
• Clinical research organizations
• Research and development (R&D) companies
• Medical device companies
• Business research and consulting service providers
• Academic medical centers/universities/hospitals

Inquire for Discount on “Clinical Trial Management System Market by End User (Pharma & Biopharmaceutical Co., Medical Device Co., CROs), Delivery Mode (Web Hosted, On-premise, Cloud-based), Type (Enterprise, Site), Component (Software, Services) - Global Forecast to 2022” report at https://www.reportsnreports.com/contacts/discount.aspx?name=126572 .

Reasons to Buy the Report -
Clinical trial management market is segmented into pharmaceutical and biopharmaceutical companies, contract research organizations, medical device companies, and others. The pharmaceutical and biopharmaceutical companies segment is further subsegmented into large pharmaceutical companies and mid-small pharmaceutical companies. The pharmaceutical and biopharmaceutical companies segment is expected to account for the largest share of the CTMS market in 2017.

About Us -
ReportsnReports is your single source for all market research needs. Our database includes 500,000+ market research reports from over 95 leading global publishers & in-depth market research studies of over 5000 micro markets.

Contact Number: + 1 888 391 5441
Email Id - sales@reportsandreports.com

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Clinical Trial Management System Market by Oracle (US), Medidata Solutions (US), PAREXEL (US), Bioclinica (US), Bio-Optronics (US), and IBM (US) and Dominated Due to Pharma & Biopharmaceutical Co., Medical Device Co., CROs End Users to 2022 here

News-ID: 1701610 • Views:

More Releases from ReportsnReports

DeviceCon Series 2024 - UK Edition | MarketsandMarkets
DeviceCon Series 2024 - UK Edition | MarketsandMarkets
Future Forward: Redefining Healthcare with Cutting-Edge Devices Welcome to DeviceCon Series 2024 - Where Innovation Meets Impact! Join us on March 21-22 at Millennium Gloucester Hotel, 4-18 Harrington Gardens, London SW7 4LH for a groundbreaking convergence of knowledge, ideas, and technology. MarketsandMarkets proudly presents the DeviceCon Series, an extraordinary blend of four conferences that promise to redefine the landscape of innovation in medical and diagnostic devices. Register Now @ https://events.marketsandmarkets.com/devicecon-series-uk-edition-2024/register MarketsandMarkets presents
5th Annual MarketsandMarkets Infectious Disease and Molecular Diagnostics Conference Promises New Trends and Insights in Diagnosis
5th Annual MarketsandMarkets Infectious Disease and Molecular Diagnostics Confer …
London, March 7, 2024 - MarketsandMarkets is thrilled to announce the eagerly awaited 5th Annual Infectious Disease and Molecular Diagnostics Conference, scheduled to take place on March 21st - 22nd, 2024, at the prestigious Millennium Gloucester Hotel, located at 4-18 Harrington Gardens, London SW7 4LH. This conference promises to be a groundbreaking event, showcasing the latest trends and insights in diagnosis, as well as unveiling cutting-edge technologies that are revolutionizing the
Infection Control, Sterilization & Decontamination Conference |21st - 22nd March 2024| Challenges and Factors affecting in Sterilization of medical devices and more
Infection Control, Sterilization & Decontamination Conference |21st - 22nd March …
MarketsandMarkets is pleased to announce its 8th Annual Infection Control, Sterilisation, and Decontamination in Healthcare Conference, which will take place March 21-22, 2024, in London, UK. With the increased risk of infection due to improper sterilisation and decontamination practices, the safety of patients and healthcare workers is of paramount importance nowadays. Enquire Now @ https://events.marketsandmarkets.com/infection-control-sterilization-and-decontamination-conference/ This conference aims to bring together all the stakeholders to discuss the obstacles in achieving
Breast Augmentation Market Key Players, Demands, Cost, Size, Procedure, Shape, Surface and Forecast to 2025
Breast Augmentation Market Key Players, Demands, Cost, Size, Procedure, Shape, S …
The global Breast Augmentation Market in terms of revenue was estimated to be worth $900 million in 2020 and is poised to reach $1,692 million by 2025, growing at a CAGR of 13.4% from 2020 to 2025. The new research study consists of an industry trend analysis of the market. The new research study consists of industry trends, pricing analysis, patent analysis, conference and webinar materials, key stakeholders, and buying

All 5 Releases


More Releases for Clinical

Clinical Laboratory Market in Indonesia, Clinical Laboratory Industry in Indones …
"Increase in healthcare expenditure from the Indonesian government has driven the growth of clinical laboratory market in Indonesia." Increase in Healthcare Awareness: Largely driven by increase in healthcare spending by aging population (~$ 260 per person by 2050), rising income levels, rising awareness for preventive testing, advanced healthcare diagnostic tests offerings, and central government's healthcare measures. Developments in Testing and Preference for Evidence based testing: There is also a rising number
Clinical solutions
Are you spending more time with yellow files than with patients? Healthbridge can change that with our intuitive and easy to use clinical platform that is designed specifically for the medical practitioner at the practice. smaller2 Easily access patient information Cloud-based technology enables you to store rich clinical information that can be easily accessed as and when you need it. Medical billing software innovation Become a paperless practice Create scripts, sick notes, and clinical notes electronically. Plus, have
Clinical Research and Clinical Trials Summit
Clinical Research 2019 has been designed in an interdisciplinary manner with a multitude of tracks to choose from every segment and provides you with a unique opportunity to meet up with peers from both industry and academia and establish a scientific network between them. We cordially invite all concerned people to come join us at our event and make it successful by your participation. This is the premier interdisciplinary forum for
Paediatric Clinical Trial Conference - When designing a Paediatric clinical tria …
Press Release – 12.02.2018 When designing a Paediatric clinical trial, a paediatric investigation plan (PIP) is a development plan aimed at ensuring that the necessary data are obtained through studies in children, to support the authorisation of a medicine for children. All applications for marketing authorisation for new medicines have to include the results of studies as described in an agreed PIP, unless the medicine is exempt because of a deferral
Clinical Communication
According to a recent market report published by Persistence Market Research titled “Clinical Communication and Collaboration Market: Global Industry Analysis (2012–2016) and Forecast (2017–2025),” revenue from the global clinical communication and collaboration market was US$ 138.5 Mn in 2012 and US$ 214.8 Mn in 2016, representing a CAGR of 11.6% from 2012 to 2016. This revenue growth is attributed to addition of new features in clinical communication and collaboration solutions.
E-Clinical Trial Solutions Market To Accelerating Clinical Development Technolog …
The study of the "Global e-Clinical Trial Solutions Market" provides the market size information and market trends along with the factors and parameters impacting it in both short and long term. The study ensures a 360° view, bringing out the complete key insights of the industry. The Global e-Clinical Trial Solutions Market Research Report Forecast 2017-2021 is a valuable source of insightful data for business strategists. It provides the e-Clinical